Did you know that there were 9.5 million newly reported cancer cases and 5.8 million cancer-related deaths occurring in Asia in 2020? These numbers are devastating! Even worse, without intervention, the number of new cases in Asia is anticipated to increase to…
HONG KONG – The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.
AFCR’s BRACE (Bridging Research from Academia to Cancer Entrepreneurship) Award Venture Competition is designed…
The Asian Fund for Cancer Research (AFCR) is thrilled to unveil its fresh brand logo and slogan, marking a pivotal moment in the organization's quest to advance breakthroughs in cancer globally. The redesigned emblem and impactful slogan firmly establish AFCR as a…
Left to right: Prof. Shi-Yong Sun, Prof. Tianzhi Huang, Prof. Lirong Zhang, Prof. Ming Yan, Prof. Qi Zhang, Prof. Yunguang Tong, Prof. Song Xu, Prof. Binghua Jiang, Prof. Xu Qian, Prof. Zigang Dong.
To foster and strengthen collaborations among cancer researchers and…
Sujuan Ba, Ph.D. has been awarded the Leadership Award for Global Advocate of Cancer Research by the Hong Kong Biotechnology Organization (HKBIO) at their BIOHK2023 Conference (13-16 September, Hong Kong Convention and Exhibition Centre). Dr. Ba is the President, CEO and Founder…
Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) of CityU (second from right) and Dr Sujuan Ba (second from left) signed the MoU, witnessed by Mr Lester Garson Huang, Council Chairman of CityU (first from right), and Ms Lillian Cheong, Under…
The U.S. Chinese Anti-Cancer Association (USCACA) and AFCR are pleased to invite nominations for the USCACA-‐AFCR 2023 Young Investigator Awards.
The Awards will recognize 3 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research.
Candidacy…
Standing Together for a Greater Cause
In a remarkable display of unity, Dr. Sujuan B., CEO of the Asian Fund for Cancer Research (AFCR), and Dr. Kwok Leung, CFO, proudly stood shoulder to shoulder with the Global Coalition for Adaptive…
FOR IMMEDIATE RELEASE:
1 February 2023
CONTACTS:
Hugill & Ip Solicitors
Marco Raccuia, Head of Finance & Operations
E-mail: marco.raccuia@hugillandip.com
World Cancer Day - held every 4 February - is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action,…
The past year has been a challenging one, but thanks to your generous support and that of other donors, we have been able to continue funding the work of scientists and even expand our research projects during a difficult period of economic…